Telemedicine during the coronavirus disease 2019 pandemic for pediatric patients with eosinophilic esophagitis

Ann Allergy Asthma Immunol. 2021 Sep;127(3):395-397. doi: 10.1016/j.anai.2021.06.013. Epub 2021 Jun 20.
No abstract available

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • COVID-19 / epidemiology*
  • Child
  • Delivery of Health Care / methods*
  • Electronic Health Records / statistics & numerical data
  • Eosinophilic Esophagitis / diagnosis
  • Eosinophilic Esophagitis / physiopathology
  • Eosinophilic Esophagitis / therapy*
  • Female
  • Humans
  • Male
  • Maryland / epidemiology
  • Office Visits / statistics & numerical data
  • Pandemics*
  • Retrospective Studies
  • SARS-CoV-2 / pathogenicity
  • Telemedicine / organization & administration*
  • Treatment Outcome
  • Videoconferencing / organization & administration

Substances

  • Anti-Inflammatory Agents